| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.3M | +79.0% |
| R&D Expense | $6.0M | -17.4% |
| SG&A Expense | $20.2M | +4.7% |
| Operating Income | -$46.1M | +5.0% |
| Interest Expense | $26K | -93.8% |
| Pre-tax Income | -$45.5M | +13.6% |
| Net Income | -$45.5M | +13.6% |
| EPS (Basic) | -$1.05 | +16.7% |
| EPS (Diluted) | -$1.05 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $22.4M | +18.3% |
| Accounts Receivable | $45K | +0.0% |
| Inventory | $341K | +22.7% |
| Current Assets | $25.1M | +13.9% |
| Total Assets | $30.7M | +12.6% |
| Current Liabilities | $23.5M | -19.9% |
| Total Liabilities | $25.3M | -14.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$44.1M | -34.5% |
| Investing Cash Flow | -$646K | -192.3% |
| Financing Cash Flow | $48.2M | +63.8% |
| +16.7% |
| Stockholders' Equity |
| $5.4M |
| +333.3% |